GoldBamboo.com - Knowledge is strong medicine
  

Prenatal Nutrition and Adult Disease - Article


  Not Signed In - Sign In / Register






Insulin aspart

Humalog Aspart; Humulin Aspart; insulin aspart [rDNA origin]; Novolin Aspart; NovoLog


Clinical Trial: Prenatal Nutrition and Adult Disease

This study is no longer recruiting patients.

Sponsored by: National Heart, Lung, and Blood Institute (NHLBI)
Information provided by: National Heart, Lung, and Blood Institute (NHLBI)

Purpose

To determine whether maternal undernutrition in pregnancy is associated with differences between siblings for cardiovascular risk factors in adulthood.

Condition
Cardiovascular Diseases
Heart Diseases
Diabetes Mellitus
Diabetes Mellitus, non-insulin dependent
Insulin Resistance
Obesity
Hypertension

MedlinePlus related topics:  Diabetes;   Heart Diseases;   Heart Diseases--Prevention;   High Blood Pressure;   Metabolic Syndrome X;   Obesity;   Vascular Diseases

Study Type: Observational
Study Design: Natural History, Defined Population

Further Study Details: 

Study start: September 2001;  Study completion: August 2005

BACKGROUND: A variety of studies have reported associations between birth weight and other proxy measures of fetal nutrition and chronic disease risk in adulthood, particularly "metabolic diseases" such as type 2 diabetes and cardiovascular disease (CVD). These findings have led to the theory of "fetal programming" of adult chronic disease. This theory is highly provocative because it suggests that the prevention of many chronic diseases should start with the improvement of materno-fetal nutrition. A mechanism for fetal programming of adult chronic disease risk, however, has not been identified. In addition, most epidemiological studies have been ecological and retrospective, with poor identification of exposure dose and timing, and control of confounders.

DESIGN NARRATIVE: The cohort study determines whether famine exposure during the first, second, or third trimesters of gestation is associated with differences between sibs for CVD risk factors in adulthood, specifically centralized obesity, insulin resistance, increased blood pressures, dyslipidemia, and diagnosed type 2 diabetes. Using the data collected, the investigators propose to: (1) evaluate the key assumption that maternal undernutrition during pregnancy results in fetal programming of CVD risk factors; (2) better identify the critical period during gestation in which this may occur; and, (3) determine the strength of the associations with chronic disease risk factors in adulthood.

The study will utilize an innovative sib-pair design in which cases, or "probands," exposed to fetal undernutrition during the Dutch Famine during 1944-45, will be matched to same-sex full siblings who were born in different years and not exposed. The timing of births within the famine period will allow the investigators to classify proband exposure approximately by trimester of gestation. Thus, compared to most previous studies, they will be better able to identify the "critical period" - early, mid, or late gestation - during which fetal programming effects are most likely to occur. In addition, the investigators will randomly select a sample of unexposed probands with birth dates in 1943 or 1947, immediately before and after the famine, and matched siblings. All exposed and unexposed probands will be ascertained from the prenatal and delivery records of three hospitals in the Western Netherlands where the famine was most intense. These records include information on maternal and family medical history, socioeconomic status, pregnancy characteristics (blood pressure, weight gain, etc.), and birth outcomes, including anthropometry and gestational age. Siblings will be identified using national Population Registers (Bevolkings registers), and hospital prenatal and delivery records will be obtained.

In addition to collecting information from perinatal hospital and registry records, all subjects will undergo a home interview and clinical examination. The interview will collect information on sociodemographic characteristics, economic status, health history, including obstetric history, current health and medical treatment, and health behaviors, including physical activity. The clinical examine will include a fasting blood draw for lipid, glucose, and insulin concentrations, and a glucose tolerance test with additional blood draws at 30 and 120 minutes post-glucose load. Blood will also be stored for future DNA isolation and assay of genetic polymorphisms that could influence associations among the study variables. Anthropometry will include height, weight, waist circumference, and abdominal sagital diameter. A food frequency questionnaire will also be administered during either the interview or examination phase.

An innovative part of the study will be measurements of hand morphology: specifically, fingertip ridge-count differences and digit-lengths. These characteristics are established by the 19th week of gestation and are fixed thereafter throughout the lifetime. There is some evidence that the development of these characteristics prior to 19 weeks of gestation may be influenced by environmental factors, including materno-fetal nutrition. The investigators will test the hypothesis that these finger and hand characteristics are markers of undernutrition during the first half of pregnancy and predict other adult CVD risk factors.

Eligibility

Ages Eligible for Study:  55 Years   -   60 Years,  Genders Eligible for Study:  Both

Criteria

No eligibility criteria

Location Information

Study chairs or principal investigators

L. Lumey,  Columbia University Health Sciences   

More Information

Publications

Stein AD, Zybert PA, Lumey LH. Acute undernutrition is not associated with excess of females at birth in humans: the Dutch hunger winter. Proc R Soc Lond B Biol Sci. 2004 May 7;271 Suppl 4:S138-41.

Stein AD, Zybert PA, Van De Bor M, Lumey LH. Intrauterine famine exposure and body proportions at birth: the Dutch Hunger Winter. Int J Epidemiol. 2004 May 27 [Epub ahead of print]

Study ID Numbers:  984
Record last reviewed:  December 2004
Last Updated:  January 10, 2005
Record first received:  September 21, 2001
ClinicalTrials.gov Identifier:  NCT00024583
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08


Source: ClinicalTrials.gov
Cache Date: April 9, 2005


Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $50 a year, a savings of 50% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

Popular Treatments

Acne Treatment ADHD Treatment Allergy Treatment Alzheimer's Treatment
Anemia Treatment Arthritis Treatment Asthma Treatment Bipolar Disorder Treatment
Bird Flu Treatment Bladder Cancer Treatment Bladder Control Treatment Blood Pressure Treatment
Brain Tumor Treatment Breast Cancer Treatment Bronchitis Treatment Cancer Treatment
Cancer Alternative Treatment Cataract Treatment Cirrhosis Treatment Colitis Treatment
Colon Cancer Treatment Common Cold Treatment Conjunctivitis Treatment Constipation Treatment
Crohn's Disease Treatment Cystic Fibrosis Treatment Depression Treatment Dermatitis Treatment
Diabetes Treatment Edema Treatment Epilepsy Treatment Erectile Dysfunction Treatment
Fibromyalgia Treatment GERD Treatment Glaucoma Treatment Gout Treatment
Hay Fever Treatment Headache Treatment Heart Disease Treatment Hepatitis Treatment
High Blood Pressure Treatment High Cholesterol Treatment Hives Treatment Hypertension Treatment
Hypoglycemia Treatment IBS Treatment Impotence Treatment Indigestion Treatment
Infertility Treatment Influenza Treatment Insomnia Treatment Lactose Intolerance Treatment
Leukemia Treatment Lung Cancer Treatment Lyme Disease Treatment Macular Degeneration Treatment
Menopause Treatment Migraine Treatment Osteoarthritis Treatment Osteoporosis Treatment
Pancreatic Cancer Treatment PMS Treatment Pneumonia Treatment Prostate Diseases Treatment
Restless Leg Treatment Rheumatoid Arthritis Treatment Sepsis Treatment Sinusitis Treatment
Skin Cancer Treatment Sleep Apnea Treatment Snoring Treatment Stroke Treatment
Testicular Cancer Treatment
GoldBambooTM

Your Integrative Health and Wellness Resource for Insulin aspart.

August 21, 2008



Page Updated: September 6, 2005
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Insurance Quotes | Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Google Co-op | Health Forums

Copyright © 2004-2008 - Gold Bamboo LLC
All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.